Literature DB >> 21359973

Transcriptional regulation and multiple functions of MAO genes.

Jean C Shih1, Jason Boyang Wu, Kevin Chen.   

Abstract

Monoamine oxidase (MAO) A and MAO B are a crucial pair of isoenzymes, which oxidatively deaminate monoamine neurotransmitters and dietary amines with a production of hydrogen peroxide. These two isoenzymes have different but overlapping substrate and inhibitor specificities. MAO A and MAO B share 70% amino acid sequence identity and show different temporal and spatial expressions in both humans and mice. Abnormal MAO A or MAO B activity has been implicated in numerous neurological and psychiatric disorders. A better understanding of the transcriptional regulation of MAO A and MAO B genes may help explain the differential tissue-specific expression of these two isoenzymes and provide insights into the molecular basis of the disorders associated with MAO dysfunction. This review discusses the recent progress in the transcriptional regulation and multiple functions of MAO A and MAO B genes.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21359973      PMCID： PMC3125068          DOI： 10.1007/s00702-010-0562-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  71 in total

1.  Treatment of depression with antiglucocorticoid drugs.

Authors:  O M Wolkowitz; V I Reus
Journal:  Psychosom Med       Date:  1999 Sep-Oct       Impact factor: 4.312

Review 2.  Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.

Authors:  M Naoi; W Maruyama; Y Akao; J Zhang; H Parvez
Journal:  Toxicology       Date:  2000-11-16       Impact factor: 4.221

3.  Gender-specific disruptions in emotion processing in younger adults with depression.

Authors:  Sara L Wright; Scott A Langenecker; Patricia J Deldin; Lisa J Rapport; Kristy A Nielson; Allison M Kade; Lawrence S Own; Huda Akil; Elizabeth A Young; Jon-Kar Zubieta
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

4.  Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.

Authors:  Shunit Gal; Hailin Zheng; Mati Fridkin; Moussa B H Youdim
Journal:  J Neurochem       Date:  2005-10       Impact factor: 5.372

5.  Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.

Authors:  R M Wu; D L Murphy; C C Chiueh
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 6.  The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.

Authors:  Moussa B H Youdim
Journal:  Curr Alzheimer Res       Date:  2006-12       Impact factor: 3.498

7.  Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat.

Authors:  D P Holschneider; T Kumazawa; K Chen; J C Shih
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.

Authors:  Anna L Scott; Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

9.  Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.

Authors:  Yael Avramovich-Tirosh; Lydia Reznichenko; Tamar Mit; Hailin Zheng; Mati Fridkin; Orly Weinreb; Silvia Mandel; Moussa B H Youdim
Journal:  Curr Alzheimer Res       Date:  2007-09       Impact factor: 3.498

10.  Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene.

Authors:  Xiao-Ming Ou; Kevin Chen; Jean C Shih
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157
View more
  29 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Janneth Oleas; Hong Xing; Yuning Liu; Kelly M Dexter; Carly Misztal; Melinda Gerard; Iakov Efimenko; Patrick Lynch; Matthew Villanueva; Raul Alsina; Shiv Krishnaswamy; David E Vaillancourt; Yuqing Li
Journal:  Neurobiol Dis       Date:  2019-10-13       Impact factor: 5.996

Review 3.  Epigenetic signature of MAOA and MAOB genes in mental disorders.

Authors:  Christiane Ziegler; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2018-09-21       Impact factor: 3.575

Review 4.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

5.  Influence of prenatal iron deficiency and MAOA genotype on response to social challenge in rhesus monkey infants.

Authors:  M S Golub; C E Hogrefe; E L Unger
Journal:  Genes Brain Behav       Date:  2012-03-13       Impact factor: 3.449

6.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Qinlong Li; Peizhen Hu; Changhong Shi; Yang Li; Yi-Ting Chen; Fei Yin; Chun-Peng Liao; Bangyan L Stiles; Haiyen E Zhau; Jean C Shih; Leland W K Chung
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

7.  Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.

Authors:  Zhaofei Yang; Xuan Wang; Jian Yang; Min Sun; Yong Wang; Xiaomin Wang
Journal:  Neurotox Res       Date:  2016-12-15       Impact factor: 3.911

8.  Monoamine Oxidase B in Renal Cell Carcinoma.

Authors:  Ingrid Hodorová; Silvia Rybárová; Peter Solár; Marián Benický; Dušan Rybár; Zuzana Kováčová; Jozef Mihalik
Journal:  Med Sci Monit       Date:  2018-08-04

9.  Hypersomnia in Mood Disorders: a Rapidly Changing Landscape.

Authors:  David T Plante
Journal:  Curr Sleep Med Rep       Date:  2015-06

10.  Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells.

Authors:  Keiko Inaba-Hasegawa; Yukihiro Akao; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2012-09-12       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.